Telomere Therapeutics appoints Dr. Michael Tadros as CEO

  • Michael is a seasoned professional in the realm of technology transfer and venture capital, skillfully connecting scientific research with commercial innovation.
  • Michael is transitioning to CEO, after proving successful leadership in gene therapy product development.

More info